Research Topics
| Peter C GøtzscheSummaryAffiliation: Det Nordiske Cochrane Center Country: Denmark Publications
| Collaborators
|
Detail Information
Publications
House dust mite control measures in the management of asthma: meta-analysisP C Gøtzsche
Nordic Cochrane Centre, Rigshospitalet, Department 7112, DK 2200 Copenhagen N, Denmark
BMJ 317:1105-10; discussion 1110. 1998..To determine whether patients with asthma who are sensitive to mites benefit from measures designed to reduce their exposure to house dust mite antigen in the home...
Is screening for breast cancer with mammography justifiable?P C Gøtzsche
Nordic Cochrane Centre, Rigshospitalet, Department 7112, Copenhagen, Denmark
Lancet 355:129-34. 2000..We therefore reviewed the methodological quality of the mammography trials and an influential Swedish meta-analysis, and did a meta-analysis ourselves...
On the benefits and harms of screening for breast cancerPeter C Gøtzsche
The Nordic Cochrane Centre, Rigshospitalet, Dept 7112, Blegdamsvej 9, DK 2100 Copenhagen Ø, Denmark
Int J Epidemiol 33:56-64; discussion 69-73. 2004
[Misleading report concerning our work on mammographic screening]Peter C Gøtzsche
Det Nordiske Cochrane Center, København
Lakartidningen 99:75-6. 2002
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional studyKarsten Juhl Jørgensen
Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 København Ø, Denmark
BMJ 328:148. 2004..To investigate whether information on mammographic screening presented on websites by interest groups is balanced, is independent of source of funding, and reflects recent findings...
[Information about breast cancer screening presented on websites is biased and insufficient--a secondary publication]Karsten Juhl Jørgensen
H S Rigshospitalet, Det Nordiske Cochrane Center, København
Ugeskr Laeger 167:174-8. 2005
Content of invitations for publicly funded screening mammographyKarsten Juhl Jørgensen
Nordic Cochrane Centre, Rigshospitalet Department 7112, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMJ 332:538-41. 2006
The debate on breast cancer screening with mammography is importantPeter C Gøtzsche
Nordic Cochrane Centre, H S Rigshospitalet, Copenhagen, Denmark
J Am Coll Radiol 1:8-14. 2004
Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort studyAndreas Lundh
The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
PLoS Med 7:e1000354. 2010..We investigated industry-supported trials' influence on journal impact factors and revenue...
[Freedom of expression and editorial independence: Four firings and a Kafkanian process]Peter C Gøtzsche
Rigshospitalet, Afsnit 3343, Det Nordiske Cochrane Center, DK 2100 København Ø
Ugeskr Laeger 170:1537-8. 2008
Why mammography screening has not lived up to expectations from the randomised trialsPeter C Gøtzsche
Dept 3343, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
Cancer Causes Control 23:15-21. 2012..We also believe it is more important to reduce the incidence of cancer than to detect it 'early.' Avoiding getting screening mammograms reduces the risk of becoming a breast cancer patient by one-third...
Overdiagnosis in organised mammography screening in Denmark. A comparative studyKarsten J Jørgensen
The Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMC Womens Health 9:36. 2009..We quantified overdiagnosis in the Danish mammography screening programme, which is uniquely suited for this purpose, as only 20% of the Danish population has been offered organised mammography screening over a long time-period...
What is publication?Peter C Gøtzsche
Nordic Cochrane Centre, HS Rigshospitalet, DK 2100 København Ø, Denmark
Lancet 368:1854-6. 2006
The breast screening programme and misinforming the publicPeter C Gøtzsche
The Nordic Cochrane Centre, Copenhagen, Denmark
J R Soc Med 104:361-9. 2011..Concerns about over-diagnosis have not been addressed either and official documents still downplay this most important harm of breast cancer screening...
Breast cancer mortality in organised mammography screening in Denmark: comparative studyKarsten Juhl Jørgensen
The Nordic Cochrane Centre, Rigshospitalet, University of Copenhagen, Denmark
BMJ 340:c1241. 2010....
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic reviewAnders W Jørgensen
Nordic Cochrane Centre, Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
BMJ 333:782. 2006..To compare the methodological quality and conclusions in Cochrane reviews with those in industry supported meta-analyses and other meta-analyses of the same drugs...
The benefits and harms of screening for cancer with a focus on breast screeningJohn Brodersen
Department and Research Unit of General Practice, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark
Pol Arch Med Wewn 120:89-94. 2010....
Intravenous alpha-1 antitrypsin augmentation therapy: systematic reviewPeter C Gøtzsche
Rigshospitalet, The Nordic Cochrane Centre, University of Copenhagen, Denmark
Dan Med Bull 57:A4175. 2010..14 to 2.14; p = 0.03) over the total course of the trials. Augmentation therapy with alpha-1 antitrypsin cannot be recommended in view of the lack of evidence of clinical benefit and the cost of treatment...
Adequacy of authors' replies to criticism raised in electronic letters to the editor: cohort studyPeter C Gøtzsche
Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMJ 341:c3926. 2010..To investigate whether substantive criticism in electronic letters to the editor, defined as a problem that could invalidate the research or reduce its reliability, is adequately addressed by the authors...
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement studyBritta Tendal
Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMJ 339:b3128. 2009..To study the inter-observer variation related to extraction of continuous and numerical rating scale data from trial reports for use in meta-analyses...
Powerful spin in the conclusion of Wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original reviewAsbjørn Hróbjartsson
Hróbjartsson, The Nordic CochraneCentre, Rigshospitalet, Department 7112, Blegdamsvej 9, DK 2100 Copenhagen Ø
J Clin Psychol 63:373-7. 2007..95 (95% confidence interval = 0.88-1.02) versus odds ratio 0.99 (95% confidence interval = 0.81-1.23). Thus, B. E. Wampold et al.'s conclusion was not substantiated by their data, and is best characterized as powerful spin. ...
Ghost authorship in industry-initiated randomised trialsPeter C Gøtzsche
Nordic Cochrane Centre, Copenhagen, Denmark
PLoS Med 4:e19. 2007..The prevalence and nature of ghost authorship in industry-initiated randomised trials is not known...
Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusionsAnders W Jørgensen
The Nordic Cochrane Centre, Department 3343, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMC Med Res Methodol 8:60. 2008..However, these studies have been restricted to certain medical specialities. We compared all industry-supported meta-analyses of drug-drug comparisons with those without industry support...
Data extraction errors in meta-analyses that use standardized mean differencesPeter C Gøtzsche
Nordic Cochrane Centre, Rigshospitalet, Copenhagen Ø, Denmark
JAMA 298:430-7. 2007..It is not known how reliable such meta-analyses are...
Believability of relative risks and odds ratios in abstracts: cross sectional studyPeter C Gøtzsche
Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
BMJ 333:231-4. 2006..To compare the distribution of P values in abstracts of randomised controlled trials with that in observational studies, and to check P values between 0.04 and 0.06...
[What is the effect of placebo interventions? A systematic review of randomized clinical trials with placebo treated and untreated patients]Asbjørn Hróbjartsson
Afdeling for Medicinsk Videskabsteori, Københavns Universitet, Panum Instituttet, DK 2200 København N
Ugeskr Laeger 164:329-33. 2002..Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this belief has not been rigorously evaluated...
[Breast cancer screening--two years after]Peter C Gøtzsche
Det Nordiske Cochrane Center, København
Ugeskr Laeger 164:204-6. 2002
Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infectionHelle Krogh Johansen
Department of Clinical Microbiology, H S Rigshospitalet, Copenhagen, Denmark
Pediatr Pulmonol 37:427-32. 2004..aeruginosa lung infection improved with time (P = 0.008). Our study shows that CF patients who are treated intensively have lower antibody responses and longer survival after acquisition of chronic P. aeruginosa lung infection...
[Albumin or physiologic saline to hypovolemic intensive care patients?]Peter C Gøtzsche
H S Rigshospitalet, Det Nordiske Cochrane Center
Ugeskr Laeger 166:3835. 2004
[Independent clinical trials are imperative]Peter C Gøtzsche
H S Rigshospitalet, Det Nordiske Cochrane Center, København
Ugeskr Laeger 167:1491-4. 2005
[Better reporting of harms in randomized trials: an extension of the CONSORT statement]Peter C Gøtzsche
Det Nordiske Cochrane Center, H S Rigshospitalet, Kobenhavn
Ugeskr Laeger 167:1520-2. 2005
[Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports]Asbjørn Hróbjartsson
H S Rigshopitalet, Det Nordiske Cochrane Center, University Health Network Toronto, Department of Medicine
Ugeskr Laeger 167:3189-91. 2005..Selective reporting of positive outcomes is associated with bias...
The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trialsLise L Gluud
The Cochrane Hepato-Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
Am J Gastroenterol 100:2431-5. 2005..However, even trials in high impact journals may be small or may have inadequate quality. Critical appraisal of individual trials is always necessary, irrespective of the place of publication...
Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studiesAsbjørn Hróbjartsson
The Nordic Cochrane Centre, Rigshospitalet, Denmark
J Clin Epidemiol 59:336-8; discussion 339-41. 2006
[COX-2 inhibitors and other non-steroidal anti-inflammatory agents--what is their future?]Peter C Gøtzsche
Afdeling 7112, H S Rigshospitalet, Det Nordiske Cochrane Center, København Ø
Ugeskr Laeger 168:1972-4. 2006..These drugs have likely caused the deaths of thousands of patients. The use of all NSAIDs should be restricted as much as possible. Drug trials should be a public enterprise...
[Paracetamol has the same effect as non-steroidal anti-inflammatory agents in acute musculoskeletal injuries]Peter C Gøtzsche
Afdeling 7112, H S Rigshospitalet, Det Nordiske Cochrane Center, København Ø
Ugeskr Laeger 168:1981-2. 2006
[Constraints on publication rights in industry-initiated clinical trials--secondary publication]Peter C Gøtzsche
H S Rigshospitalet, Det Nordiske Cochrane Center, DK 2100 København Ø
Ugeskr Laeger 168:2467-9. 2006..These facts were not noted in any of the trial reports. We found similar constraints on publication rights in 44 protocols from 2004. This tight sponsor control over industry-initiated trials should be changed...
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trendsKarsten Juhl Jørgensen
The Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMJ 339:b2587. 2009..To estimate the extent of overdiagnosis (the detection of cancers that will not cause death or symptoms) in publicly organised screening programmes...
General health checks in adults for reducing morbidity and mortality from diseaseLasse T Krogsbøll
The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
Cochrane Database Syst Rev 10:CD009009. 2012..Also, screening leads to increased use of diagnostic and therapeutic interventions, which can be harmful as well as beneficial. It is, therefore, important to assess whether general health checks do more good than harm...
General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysisLasse T Krogsbøll
Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
BMJ 345:e7191. 2012..To quantify the benefits and harms of general health checks in adults with an emphasis on patient-relevant outcomes such as morbidity and mortality rather than on surrogate outcomes...
Readers as research detectivesPeter C Gøtzsche
The Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100, Copenhagen Ø, Denmark
Trials 10:2. 2009..The prevailing culture of secrecy and ownership to data is not in the best interests of patients...
Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agentsAnne K Due
Nordic Cochrane Centre, Rigshospitalet, Dept, 7112, Blegdamsvej 9, DK 2100 København Ø, Denmark
BMC Med Res Methodol 6:40. 2006..We explored whether use of fungal infection-related mortality as outcome rather than total mortality leads to bias in trials of antifungal agents in cancer patients...
Sponsors' participation in conduct and reporting of industry trials: a descriptive studyAndreas Lundh
The Nordic Cochrane Centre, Rigshospitalet, Dept 7811, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
Trials 13:146. 2012..We investigated sponsors' involvement in the conduct and reporting of industry-sponsored trials...
Regular health checks: cross-sectional surveyChristian Grønhøj Larsen
Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
PLoS ONE 7:e33694. 2012..To investigate whether Danish providers of general health checks present a balanced account of possible benefits and harms on their websites and whether the health checks are evidence-based...
Why we need easy access to all data from all clinical trials and how to accomplish itPeter C Gøtzsche
Nordic Cochrane Centre, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark
Trials 12:249. 2011..I propose the contents of such legislation and of appropriate sanctions to hold accountable those who refuse to share their data...
Relation between breast cancer mortality and screening effectiveness: systematic review of the mammography trialsPeter C Gøtzsche
The Nordic Cochrane Centre, Department 3343, Rigshospitalet, 2100 Copenhagen Ø, Denmark
Dan Med Bull 58:A4246. 2011..Given that the size of the bias was similar to the estimated screening effect, screening appeared ineffective...
Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort studyJeppe Lerche la Cour
Copenhagen Trial Unit, Rigshospitalet, Copenhagen University Hospital, DK 2100 Copenhagen, Denmark
BMJ 341:c3653. 2010..To assess if authors of randomised clinical trials convey the fact that they have used surrogate outcomes and discussed their validity...
Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictoryAsbjørn Hróbjartsson
The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
J Clin Epidemiol 62:967-73. 2009..To compare the reporting on blinding in protocols and articles describing randomized controlled trials...
What should be done to tackle ghostwriting in the medical literature?Peter C Gøtzsche
Nordic Cochrane Centre, Copenhagen, Denmark
PLoS Med 6:e23. 2009..This debate examines how best to tackle ghostwriting in the medical literature from the perspectives of a researcher, an editor, and the professional medical writer...
Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groupsMatias Vested Madsen
Nordic Cochrane Centre, Rigshospitalet, Department 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMJ 338:a3115. 2009..To study the analgesic effect of acupuncture and placebo acupuncture and to explore whether the type of the placebo acupuncture is associated with the estimated effect of acupuncture...
Unbalanced reporting of benefits and harms in abstracts on rofecoxibAnders W Jørgensen
The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
Eur J Clin Pharmacol 66:341-7. 2010..From the patient's point of view, both effects are important and should be investigated and reported similarly. We studied how they have been reported over time...
Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic reviewJulie Pildal
The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
Clin Infect Dis 39:38-46. 2004..61 (95% CI, 0.50-0.73). Because high-quality trials failed to demonstrate a reduction in mortality, polyclonal immunoglobulin should not be used for treatment of sepsis except in randomized clinical trials...
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studiesAndreas Lundh
Nordic Cochrane Centre, Rigshospitalet Dept, 3343, Blegdamsvej 9, DK 2100 Copenhagen Ø, Denmark
BMC Med Res Methodol 8:22. 2008..Assessing the risk of bias in individual studies in a systematic review can be done using individual components or by summarizing the study quality in an overall score...
Divine intervention? A Cochrane review on intercessory prayer gone beyond science and reasonKarsten Juhl Jørgensen
Dept 3343, The Nordic Cochrane Centre, Rigshospitalet, DK 2100 Copenhagen, Denmark
J Negat Results Biomed 8:7. 2009..The review fails to live up to the high standards required for Cochrane reviews...
Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional studyJeppe B Schroll
Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Denmark
BMC Med Res Methodol 11:22. 2011....
Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional studyKarsten Juhl Jørgensen
The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark
BMC Med 5:12. 2007..We wanted to determine if a similar imbalance occurs in scientific articles on mammography screening and if it is related to author affiliation...
Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active interventionLasse Theis Krogsbøll
The Nordic Cochrane Centre, Rigshospitalet, Dept, 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMC Med Res Methodol 9:1. 2009..It is not known to which extent spontaneous improvement, effect of placebo and effect of active interventions contribute to the observed change from baseline, and we aimed at quantifying these contributions...
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort studyJulie Pildal
Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
BMJ 330:1049. 2005....
Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic reviewGloria Cordoba
Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
BMJ 341:c3920. 2010..To study how composite outcomes, which have combined several components into a single measure, are defined, reported, and interpreted...
Physical activity for secondary prevention of disease. Systematic reviews of randomised clinical trialsKatrine Karmisholt
Nordic Cochrane Centre, H:S Rigshospitalet, , Denmark
Dan Med Bull 52:90-4. 2005....
